Abstract
Introduction: HER2 overexpression is present in 7 to 34% of gastric carcinomas. Several studies have demonstrated associations between HER2 overexpression and clinicopathological variables, including tumor depth, lymph node metastasis, and intestinal morphology. HER2 overexpression has been linked to shorter survival. Aim: In this study, we aimed to determine the frequency of HER2 overexpression in patients with metastatic gastric carcinoma referred to our clinic, to assess HER2 expression using immunohistochemistry (IHC) or silver in situ hybridization (SISH) and to demonstrate potential associations between HER2 expression and histopathological parameters. Materials and Methods: In this study, we assessed archival samples from 120 patients diagnosed with metastatic gastric carcinoma between 2015 and 2019 and tested for HER2 status. Samples had been obtained by endoscopic biopsy in 84 patients and gastric resection in 36 patients, whereas 36 patients were diagnosed in other health facilities and were referred to our department for consulting. Hematoxylin-eosin stained preparations were reassessed, and diagnoses were confirmed based on World Health Organization (WHO), and Lauren classifications and HER2 results were compared to previous results. HER2 status was assessed by immunohistochemistry (IHC) or silver in situ hybridization (SISH) in available paraffin-embedded tumor sections. Associations between HER2 expression levels and age, sex, tumor location, size and histological type of the tumor, lymphovascular, perineural and perinodal invasion and perinodal invasion, lymph node metastasis, and site of metastasis. Results: 84 (70%) out of 120 patients with metastatic gastric carcinoma were male, and 36 (30%) were female, and the mean age was 60.7 years (age range: 21-90 years). 84 patients had undergone an endoscopic biopsy, and 36 patients had undergone gastric resection, whereas 39 patients were diagnosed in other health facilities and were referred to our department for consulting. In total 31(25.8%) out of 120 subjects tested positive for HER2 overexpression Comparisons of histological patterns, according to Lauren's classification, indicated that intestinal type was predominant in both groups, and none of the diffuse gastric carcinomas was HER2 positive. A statistically significant intergroup difference was found with respect to the prevalence of diffuse gastric carcinoma (p=0.03). Conclusion: In our study, HER-2 gene amplification (25.8%) is compatible with the literature. Her2 positive tumors were mostly located proximally and were not observed in diffuse type. In this respect, they were found statistically significant. Keywords: Her2,SISH,Gastric Carcinoma Original Article: DOI: 10.7176/JHMN/79-07 Publication date: August 31 st 2020
Highlights
HER2 overexpression is present in 7 to 34% of gastric carcinomas
Aim: In this study, we aimed to determine the frequency of HER2 overexpression in patients with metastatic gastric carcinoma referred to our clinic, to assess HER2 expression using immunohistochemistry (IHC) or silver in situ hybridization (SISH) and to demonstrate potential associations between HER2 expression and histopathological parameters
Samples had been obtained by endoscopic biopsy in 84 patients and gastric resection in 36 patients, whereas 36 patients were diagnosed in other health facilities and were referred to our department for consulting
Summary
Several studies have demonstrated associations between HER2 overexpression and clinicopathological variables, including tumor depth, lymph node metastasis, and intestinal morphology. Aim: In this study, we aimed to determine the frequency of HER2 overexpression in patients with metastatic gastric carcinoma referred to our clinic, to assess HER2 expression using immunohistochemistry (IHC) or silver in situ hybridization (SISH) and to demonstrate potential associations between HER2 expression and histopathological parameters. Her positive tumors were mostly located proximally and were not observed in diffuse type In this respect, they were found statistically significant. An increased copy number of the gene encoding the receptor protein in the nucleus, namely gene amplification is investigated with in situ hybridization (ISH) techniques including fluorescence ISH (FISH), chromogenic ISH (CISH) and silver- enhanced ISH (SISH) (5)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.